C17 Council
@C17Council
Followers
796
Following
2K
Media
563
Statuses
6K
An organization composed of the institutionally appointed heads of the sixteen pediatric hematology, oncology, and stem cell transplant programs across Canada.
Edmonton, AB
Joined July 2020
Lest We Forget On this Remembrance Day, the C17 Council honours the courage, sacrifice, and unwavering commitment of the Canadian Armed Forces members—past and present—who have served our country with distinction.
0
0
0
Pediatric Blood Cancer Research Innovation Grant
bloodcancers.ca
LLSC is the largest voluntary health organization dedicated to funding research, finding cures and ensuring access to treatments for blood cancer patients.
0
0
0
Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma
pubmed.ncbi.nlm.nih.gov
In sum, this cohort increases our clinical and biological understanding of this rare disease, provides insights for improving patient care, and directs future clinical trials and basic science...
0
0
0
Since 2005, C17 has awarded over $6.5M in research grants to advance pediatric cancer care. From zebrafish models to precision diagnostics, we’re funding the future. 🧬 https://t.co/4ruQhajWdv
#C17Grants #PediatricResearch
0
0
1
📢 Calling all health data users! Register now for the new Health Data User Webinar Series to explore how health data can support your research and decision making. https://t.co/iLbCUhjNSE
#CdnHealth
0
1
1
Prevalence of childhood cancer in Canada: an analysis using 5-year, 18-year and 25-year limited-duration prevalence from the CYP-C data tool #CYPC_CCJC
canada.ca
In this study we describe the prevalence of childhood cancer in Canada by type, geographic region, year, age group and sex, using publicly available data in the Cancer in Young People in Canada...
0
0
0
"health—and especially children’s health—must be the proving ground for Canada’s AI strategy."
0
0
0
A multicenter observational cohort study in survivors of Down Syndrome-associated acute leukemia (ALTE22C1): a report from the Children's Oncology Group
bmccancer.biomedcentral.com
0
0
0
Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual Disease
ashpublications.org
Key Points. Intensification of chemotherapy for ML-DS based on positive MRD did not improve survival but increased the risk for neutropenia and sepsis.Prop
0
0
0
Canadian blood cancer researchers are invited to submit proposals to The Leukemia & Lymphoma Society of Canada (LLSC)'s Operating Grant Program Competition.
bloodcancers.ca
LLSC is the largest voluntary health organization dedicated to funding research, finding cures and ensuring access to treatments for blood cancer patients.
0
1
2
Defining and measuring tolerability in pediatric, adolescent, and young adult oncology: The essential voices
pubmed.ncbi.nlm.nih.gov
In this review on the status of tolerability in pediatric oncology, the authors address the relevance and meaning of this important concept and offer a definition to represent treatment tolerability...
0
0
2
This National Pain Awareness Week, people are still needlessly experiencing unmanaged pain. Find out what can be done to address it and look at how far we've come in the implementation of the Action Plan for Pain in Canada. #NPAW2025
https://t.co/m4hq8pTUCR
4
3
6
Academic and Patient Scholars engaging with the broader BioCanRx network through pre-summit virtual webinars, attendance at the Summit4CI conference, and the co-creation of the Learning Institute Dissemination report.
0
0
0
Cancer-associated fibroblasts promote tumor progression in fusion-positive rhabdomyosarcoma
pmc.ncbi.nlm.nih.gov
In children, rhabdomyosarcoma is the most common tumor originating in soft connective tissue. The PAX3/PAX7-FOXO1 fusion-positive alveolar subtype has poor clinical outcomes, with frequent recurren...
0
0
0
The human crisis in cancer: a Lancet Oncology Commission
pubmed.ncbi.nlm.nih.gov
Amid unprecedented scientific progress in oncology, a growing body of evidence reveals a parallel and profound crisis in the human experience of cancer care. Despite overall survival outcomes...
0
0
0
Nearly 1 in 5 children with cancer won’t survive. The 100% Fund targets hard-to-treat cancers with bold research. Because every child deserves a cure. 💪 https://t.co/3RPZvpKe5k
#100PercentFund #HopeForKids
0
0
0
🧬 https://t.co/1jiBjiuXIn — your trusted source for info on childhood cancer clinical trials in Canada. Stay informed about open trials, closed studies, and their results. Empowering health professionals, patients & families. #ChildhoodCancer #ClinicalTrialsCanada
0
0
0
Diffuse pontine glioma (DPG): shorter or longer treatment time?
pubmed.ncbi.nlm.nih.gov
Given their shorter life expectancy, poor-risk patients may benefit from HR. We propose a scoring system based on prognostic factors to guide decisions between HR and normal fractionation.
0
0
0
Enhancing Circle-of-Care Communication in Pediatric Cancer Through Digital Health Technologies: A Scoping Review
pubmed.ncbi.nlm.nih.gov
Effective communication in pediatric cancer care is crucial for informed decision-making among patients, caregivers, and healthcare providers. This scoping review assesses evidence on digital tools...
0
0
0